logo_casma-therapeutics.png
Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference
May 17, 2022 16:01 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to provide innovative new medicines, today announced that Keith...
logo_casma-therapeutics.png
Casma Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference
April 07, 2022 16:30 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to design innovative new medicines, today announced that Casma...
logo_casma-therapeutics.png
Casma Therapeutics to Present at 2021 Stifel Virtual Healthcare Conference
November 10, 2021 16:01 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the power of autophagy to design innovative new medicines, today announced that Chief...
logo_casma-therapeutics.png
Casma Therapeutics Announces Publication in Science Advances Highlighting Novel Mechanism Related to TFEB Activation and Lysosomal Biology
October 04, 2021 08:00 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design new medicines, today announced the publication of...
logo_casma-therapeutics.png
Casma Therapeutics to Present at the UBS Virtual Biotechnology Private Company Symposium
September 15, 2021 16:05 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that...
logo_casma-therapeutics.png
Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
September 13, 2021 08:00 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced the...
logo_casma-therapeutics.png
Casma Therapeutics to Present at Oppenheimer Rare & Orphan Disease Summit
May 14, 2021 08:00 ET | Casma Therapeutics, Inc.
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Chief...